UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 72 filers reported holding UROGEN PHARMA LTD in Q3 2018. The put-call ratio across all filers is - and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $140,899 | +1.9% | 10,057 | -24.7% | 0.00% | – |
| Q2 2023 | $138,224 | -82.4% | 13,355 | -84.3% | 0.00% | – |
| Q1 2023 | $784,199 | -43.3% | 84,870 | +18.3% | 0.00% | – |
| Q3 2020 | $1,383,000 | -26.9% | 71,738 | -0.9% | 0.00% | – |
| Q2 2020 | $1,891,000 | +632.9% | 72,366 | +400.1% | 0.00% | – |
| Q1 2020 | $258,000 | -75.6% | 14,469 | -54.4% | 0.00% | -100.0% |
| Q4 2019 | $1,058,000 | +366.1% | 31,719 | +595.1% | 0.00% | 0.0% |
| Q2 2018 | $227,000 | – | 4,563 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ProQuest Associates IV LLC | 789,297 | $39,275,000 | 60.44% |
| Wildcat Capital Management, LLC | 251,459 | $12,513,000 | 9.57% |
| Consonance Capital Management LP | 1,487,491 | $74,018,000 | 4.77% |
| MENORA MIVTACHIM HOLDINGS LTD. | 2,499,870 | $124,394,000 | 3.53% |
| MEITAV INVESTMENT HOUSE LTD | 509,355 | $29,967,000 | 1.34% |
| DSAM Partners (London) Ltd | 127,588 | $6,349,000 | 1.28% |
| SHIKIAR ASSET MANAGEMENT INC | 48,125 | $2,395,000 | 1.00% |
| BANK HAPOALIM BM | 67,125 | $3,340,000 | 0.91% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 331,900 | $16,515,000 | 0.55% |
| Clal Insurance Enterprises Holdings Ltd | 310,000 | $15,426,000 | 0.40% |